关注
Ji Hyeon Kim
Ji Hyeon Kim
在 stanford.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Multifunctional sonosensitizers in sonodynamic cancer therapy
S Son, JH Kim, X Wang, C Zhang, SA Yoon, J Shin, A Sharma, MH Lee, ...
Chemical Society Reviews 49 (11), 3244-3261, 2020
6642020
Unimolecular Photodynamic O2-Economizer To Overcome Hypoxia Resistance in Phototherapeutics
M Li, Y Shao, JH Kim, Z Pu, X Zhao, H Huang, T Xiong, Y Kang, G Li, ...
Journal of the American Chemical Society 142 (11), 5380-5388, 2020
2692020
Cancer stem cell-targeted bio-imaging and chemotherapeutic perspective
J Han, M Won, JH Kim, E Jung, K Min, P Jangili, JS Kim
Chemical Society Reviews 49 (22), 7856-7878, 2020
1312020
Nanomaterial designing strategies related to cell lysosome and their biomedical applications: A review
B Rathore, K Sunwoo, P Jangili, J Kim, JH Kim, M Huang, J Xiong, ...
Biomaterials 211, 25-47, 2019
1062019
Post-synthetic modifications in porous organic polymers for biomedical and related applications
JH Kim, DW Kang, H Yun, M Kang, N Singh, JS Kim, CS Hong
Chemical Society Reviews 51 (1), 43-56, 2022
842022
Engineering of BODIPY-based theranostics for cancer therapy
Z Mao, JH Kim, J Lee, H Xiong, F Zhang, JS Kim
Coordination Chemistry Reviews 476, 214908, 2023
742023
A small molecule strategy for targeting cancer stem cells in hypoxic microenvironments and preventing tumorigenesis
JH Kim, P Verwilst, M Won, J Lee, JL Sessler, J Han, JS Kim
Journal of the American Chemical Society 143 (35), 14115-14124, 2021
632021
Nanoscale materials-based platforms for the treatment of bone-related diseases
X Zhang, S Koo, JH Kim, X Huang, N Kong, L Zhang, J Zhou, J Xue, ...
Matter 4 (9), 2727-2764, 2021
572021
Immunosonodynamic therapy designed with activatable sonosensitizer and immune stimulant imiquimod
H Lei, JH Kim, S Son, L Chen, Z Pei, Y Yang, Z Liu, L Cheng, JS Kim
ACS nano 16 (7), 10979-10993, 2022
532022
Engineered metallacycle‐based supramolecular Photosensitizers for effective Photodynamic Therapy
L Tu, C Li, X Xiong, J Hyeon Kim, Q Li, L Mei, J Li, S Liu, J Seung Kim, ...
Angewandte Chemie 135 (15), e202301560, 2023
522023
DNA‐damage‐response‐targeting mitochondria‐activated multifunctional prodrug strategy for self‐defensive tumor therapy
P Jangili, N Kong, JH Kim, J Zhou, H Liu, X Zhang, W Tao, JS Kim
Angewandte Chemie International Edition 61 (16), e202117075, 2022
412022
Emetine‐Loaded Black Phosphorus Hydrogel Sensitizes Tumor to Photothermal Therapy through Inhibition of Stress Granule Formation
J Xie, T Fan, JH Kim, Y Xu, Y Wang, W Liang, L Qiao, Z Wu, Q Liu, W Hu, ...
Advanced Functional Materials 30 (43), 2003891, 2020
402020
Side-chain engineering of diketopyrrolopyrrole-based hole-transport materials to realize high-efficiency perovskite solar cells
A Sharma, R Singh, GP Kini, J Hyeon Kim, M Parashar, M Kim, M Kumar, ...
ACS Applied Materials & Interfaces 13 (6), 7405-7415, 2021
302021
Wavelength engineerable porous organic polymer photosensitizers with protonation triggered ROS generation
J Shin, DW Kang, JH Lim, JM An, Y Kim, JH Kim, MS Ji, S Park, D Kim, ...
Nature communications 14 (1), 1498, 2023
222023
Cancer Cell‐Specific Fluorescent Prodrug Delivery Platforms
S Ma, JH Kim, W Chen, L Li, J Lee, J Xue, Y Liu, G Chen, B Tang, W Tao, ...
Advanced Science 10 (16), 2207768, 2023
182023
Promoted Type I and II ROS generation by a covalent organic framework through sonosensitization and PMS activation
DW Kang, JH Kim, JH Lim, Y Kim, M Kang, J Shin, S Son, H Yun, H Kim, ...
Acs Catalysis 12 (15), 9621-9628, 2022
172022
A synchronized dual drug delivery molecule targeting cancer stem cells in tumor heterogeneity and metastasis
JH Kim, JM Park, E Jung, J Lee, J Han, YJ Kim, JY Kim, JH Seo, JS Kim
Biomaterials 289, 121781, 2022
162022
A pH‐Responsive Glycyrrhetinic‐Acid‐Modified Small‐Molecule Conjugate for NIR Imaging of Hepatocellular Carcinoma (HCC)
H Singh, JY Lim, A Sharma, DW Yoon, JH Kim, Z Yang, J Qu, J Kim, ...
ChemBioChem 20 (4), 614-620, 2019
162019
Self-activating therapeutic nanoparticle: a targeted tumor therapy using reactive oxygen species self-generation and switch-on drug release
RH Kang, Y Kim, JH Kim, NH Kim, HM Ko, SH Lee, I Shim, JS Kim, ...
ACS applied materials & interfaces 13 (26), 30359-30372, 2021
142021
A dual-action niclosamide-based prodrug that targets cancer stem cells and inhibits TNBC metastasis
JH Kim, S Park, E Jung, J Shin, YJ Kim, JY Kim, JL Sessler, JH Seo, ...
Proceedings of the National Academy of Sciences 120 (21), e2304081120, 2023
132023
系统目前无法执行此操作,请稍后再试。
文章 1–20